PROM1 and gastric cancer: MSI-H GC tumors frequently show elevated mutation abundance and we also found high CD133 expression signatures in hypermutated GC tumors (Fig. 3d; P = 2.0e-07) with a significant correlation of the CD133 expression signatures and increased mutation burdens across individual GC tumors (Fig. 3f; P < 2.2e-16).